NYSE ARCA | ETF
Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries.
While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 3.41% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 2.93% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 2.89% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 2.80% |
| MDT | Medtronic PLC | Healthcare | Medical Devices | 2.80% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 2.71% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 2.55% |
| MTD | Mettler-Toledo International Inc | Healthcare | Diagnostics & Research | 2.53% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 2.50% |
| XTSLA | BlackRock Cash Funds Treasury SL Agency | 2.50% | ||
| MRNA | Moderna Inc | Healthcare | Biotechnology | 2.36% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.14% |
| NOVN | Novartis AG | Healthcare | Drug Manufacturers - General | 2.10% |
| COO | The Cooper Companies Inc. | Healthcare | Medical Instruments & Supplies | 2.10% |
| NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 2.04% |
| GEN | Genmab A/S | Other | Other | 2.01% |
| LH | Laboratory Corporation of America Holdings | Healthcare | Diagnostics & Research | 1.99% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 1.90% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 1.89% |
| A | Agilent Technologies Inc | Healthcare | Diagnostics & Research | 1.80% |